Global Health Limited has informed the Exchange about Copy of Newspaper Publication
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) has submitted newspaper clippings of its audited consolidated and standalone financial results for Q4 FY25 and the full financial year ended March 31, 2025, published in Financial Express (English) and Jansatta (Hindi) on May 16, 2025. The results were approved by the Board on May 15, 2025. On a standalone basis, FY25 revenue from operations grew to ₹32,041.46 million from ₹29,747.24 million in FY24, but net profit after tax dipped to ₹4,615.28 million from ₹4,863.51 million. Q4 FY25 standalone net profit after tax fell to ₹934.12 million from ₹1,094.31 million in Q4 FY24. On a consolidated basis, FY25 net profit after tax rose marginally to ₹4,813.18 million from ₹4,780.60 million, while Q4 FY25 consolidated net profit after tax declined to ₹1,013.78 million from ₹1,273.47 million. FY25 EPS stood at ₹17.92 versus ₹17.80 in FY24.
Filing is a routine regulatory compliance under SEBI Listing Regulations (Reg 30 and 47) — newspaper publication of already-approved results, with no new material information. The underlying numbers show mixed performance: revenue growth but profitability pressure in Q4, which shareholders should monitor.